Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Study of Sonographic Efficacy of Rituximab in Rheumatoid Arthritis

NCT: NCT01765374 · COMPLETED

NCT IDNCT01765374

StatusCOMPLETED

Brief Summary

To detect by sonography relapse of disease activity prior to clinical symptoms in RA patients treated by rituximab.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑